Closed
Website redesign and redevelopment
Capital City College
- Value
- £250,000
- Published
- 22 Sept 2026
- Deadline
- 27 Oct 2026
- Procedure
- Competitive flexible procedure
- Category
- 72212224 — Web page editing software development services; 72212480 — Sales, marketing and business intelligence software development services; 72413000 — World wide web (www) site design services; 72414000 — Web search engine providers; 72415000 — World wide web (www) site operation host services; 79340000 — Advertising and marketing services
- Location
- UKI, United Kingdom
- Notice reference
- 089873-2026
Requirements summary
Capital City College is procuring a website redevelopment contractor to research, design, build and launch a new College website intended to be its most effective recruitment, information and self-service channel. The website must go live as soon as possible and no later than 30 September 2027, with an initial term of about 18 months including 12 months of maintenance. The fixed budget is £250,000 including VAT, with extension options available.
Key requirements
- Website redevelopment contractor to research, design, build and launch a new College website
- New website live as soon as possible and no later than 30 September 2027, with no tolerance for slippage
- Initial term of about 18 months including 12 months maintenance, with extension options up to 30 September 2032
- Fixed budget of £250,000 including VAT
- WCAG 2.2 AA accessibility as an ongoing obligation, verified by independent audit
- Content migration with joint working within College term-time constraints
- Performance and availability at seasonal peaks, and integration with third-party systems outside College control
Similar open notices
- Belfast Stories – Story EngineBelfast City Council
- Virtual Accessibility ToursNETWORK RAIL INFRASTRUCTURE LIMITED
- LPFT WebsiteLeeds and York Partnership NHS Foundation Trust
- Glasgow Business Growth Framework - Phase 4Glasgow City Council
- Concession Contract for Publishing, Selling and Marketing of the British PharmacopoeiaMHRA